Irritable Bowel Syndrome

被引:39
作者
Weaver, Kristen Ronn [1 ,2 ]
Melkus, Gail D'Eramo [3 ,4 ]
Henderson, Wendy A. [5 ]
机构
[1] NINR, Digest Disorders Unit, NIH, Bethesda, MD 20892 USA
[2] NYU, Rory Meyers Coll Nursing, New York, NY 10003 USA
[3] NYU, Rory Meyers Coll Nursing, Res, New York, NY 10003 USA
[4] NYU, Rory Meyers Coll Nursing, Nursing Res, New York, NY 10003 USA
[5] NINR, Digest Disorders Unit, NIH, Bethesda, MD 20892 USA
关键词
irritable bowel syndrome; Rome criteria; treatment approaches; FECAL MICROBIOTA TRANSPLANTATION; SELF-MANAGEMENT INTERVENTION; ECONOMIC-IMPACT; DIAGNOSTIC-TEST; HEALTH-CARE; SYMPTOMS; EPIDEMIOLOGY; ACUPUNCTURE; PREVALENCE; BIOMARKERS;
D O I
10.1097/01.NAJ.0000520253.57459.01
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Irritable bowel syndrome (IBS) is a common, chronic gastrointestinal (GI) condition characterized by disturbances in bowel habits and abdominal pain in the absence of known organic pathology. IBS reduces quality of life and is costly to treat. It is diagnosed using the symptom-based Rome criteria for functional GI disorders, which was recently updated and released as Rome IV. Both physiologic and psychological variables play a role in the etiology of IBS and perpetuate symptoms. Although research has shed light on IBS pathophysiology, therapeutic interventions remain symptom driven, employing both pharmacologic and nonpharmacologic approaches. Here, the authors review the epidemiology and pathophysiology of IBS, summarize diagnostic and treatment strategies, and discuss implications for nursing practice.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 61 条
[1]   The Effect of Irritable Bowel Syndrome on Health-Related Quality of Life and Health Care Expenditures [J].
Agarwal, Nikhil ;
Spiegel, Brennan M. R. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2011, 40 (01) :11-+
[2]   Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype [J].
Aziz, Imran ;
Trott, Nick ;
Briggs, Rebecca ;
North, John R. ;
Hadjivassiliou, Marios ;
Sanders, David S. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (05) :696-U99
[3]  
Barbara G, 2016, GASTROENTEROLOGY, V18
[4]   Fecal microbiota transplantation and emerging applications [J].
Borody, Thomas J. ;
Khoruts, Alexander .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (02) :88-96
[5]   Validating biomarkers of treatable mechanisms in irritable bowel syndrome [J].
Camilleri, M. ;
Shin, A. ;
Busciglio, I. ;
Carlson, P. ;
Acosta, A. ;
Bharucha, A. E. ;
Burton, D. ;
Lamsam, J. ;
Lueke, A. ;
Donato, L. J. ;
Zinsmeister, A. R. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (12) :1677-1685
[6]   Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms [J].
Camilleri, Michael .
JOURNAL OF PHYSIOLOGY-LONDON, 2014, 592 (14) :2967-2980
[7]   Review article: the economic impact of the irritable bowel syndrome [J].
Canavan, C. ;
West, J. ;
Card, T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) :1023-1034
[8]   The epidemiology of irritable bowel syndrome [J].
Canavan, Caroline ;
West, Joe ;
Card, Timothy .
CLINICAL EPIDEMIOLOGY, 2014, 6 :71-80
[9]   Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD [J].
Casen, C. ;
Vebo, H. C. ;
Sekelja, M. ;
Hegge, F. T. ;
Karlsson, M. K. ;
Ciemniejewska, E. ;
Dzankovic, S. ;
Froyland, C. ;
Nestestog, R. ;
Engstrand, L. ;
Munkholm, P. ;
Nielsen, O. H. ;
Rogler, G. ;
Simren, M. ;
Ohman, L. ;
Vatn, M. H. ;
Rudi, K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (01) :71-83
[10]   Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome [J].
Chey, William D. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (03) :366-371